Exelon
NDC 54868-6070
Product Information
Exelon is a NDA-approved product labeled by Physicians Total Care, Inc.. Rivastigmine is used to treat confusion (dementia) related to Alzheimer's disease and to Parkinson's disease. It is supplied as a product. This product entry covers the primary NDC 54868-6070 and its associated package configuration. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Labeler & Regulatory Data
Marketing Timeline
Code Structure Chart
Product Details
What is NDC 54868-6070?
What are the uses of this product?
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- RIVASTIGMINE (UNII: PKI06M3IW0)
- RIVASTIGMINE (UNII: PKI06M3IW0) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- ALPHA-TOCOPHEROL (UNII: H4N855PNZ1)
What is the NDC to RxNorm Crosswalk for this product?
- RxCUI: 725021 - rivastigmine 4.6 MG/Day 24HR Transdermal System
- RxCUI: 725021 - 24 HR rivastigmine 0.192 MG/HR Transdermal System
- RxCUI: 725021 - rivastigmine 0.192 MG/HR 24 HR Transdermal Patch
- RxCUI: 725021 - rivastigmine 4.6 MG/Day 24 HR Transdermal Patch
- RxCUI: 725023 - rivastigmine 9.5 MG/Day 24HR Transdermal System
* Please review the full disclaimer at the bottom of this page.